NASDAQ:TECH

Bio-techne Stock Insider Trading

Healthcare > Biotechnology

Buy TECH

*Your capital is at risk

$50.85

+1.08 (+2.17%)

At Close: Jun 03, 2026

Bio-Techne Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 30.84. In total, the insiders bought 1M and sold 279.65K TECH shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	30.84
● Buy	1M shares
● Sell	279.65K shares
78% Buy Activity Weak Positive Correlation
Buy Signal Medium Confidence Mar 02, 2026 Analysis Breakdown: Supported by a positive Insider Power Score of 30.84. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (78% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
May 08, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Herr Amy E. Director	Director	6 636 Value: $315.9K
May 08, 2026 Buy	Common Stock M-Exempt	Herr Amy E. Director	Director	6 636 Value: $315.9K
May 08, 2026 Sell	Common Stock S-Sale	Herr Amy E. Director	Director	6 636 Value: $320.4K
May 05, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Kelderman Kim Chief Executive Officer	CEO / President	26 692 Value: $1.27M
May 05, 2026 Buy	Common Stock M-Exempt	Kelderman Kim Chief Executive Officer	CEO / President	26 692 Value: $1.27M
May 05, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Bohnen Shane SVP - General Counsel	Officer	8 400 Value: $399.8K
May 05, 2026 Sell	Common Stock F-InKind	Bohnen Shane SVP - General Counsel	Officer	7 055 Value: $399.9K
May 05, 2026 Buy	Stock Options (Right to Buy) M-Exempt	Hippel James CFO	C-Suite Officer	62 000 Value: $2.95M
May 05, 2026 Sell	Common Stock F-InKind	Hippel James CFO	C-Suite Officer	56 955 Value: $3.23M
May 05, 2026 Buy	Common Stock M-Exempt	Hippel James CFO	C-Suite Officer	62 000 Value: $2.95M
May 05, 2026 Buy	Common Stock M-Exempt	Bohnen Shane SVP - General Counsel	Officer	8 400 Value: $399.8K
May 05, 2026 Sell	Common Stock F-InKind	Kelderman Kim Chief Executive Officer	CEO / President	23 951 Value: $1.36M
May 01, 2026 Buy	Restricted Stock Units M-Exempt	Crouse Steven C. President - Diag & Spatial Bi	CEO / President	794 Value: $43.7K
May 01, 2026 Sell	Common Stock F-InKind	Crouse Steven C. President - Diag & Spatial Bi	CEO / President	311 Value: $17.1K
May 01, 2026 Buy	Common Stock M-Exempt	Crouse Steven C. President - Diag & Spatial Bi	CEO / President	794 Value: $43.7K
Apr 22, 2026 Sell	Common Stock F-InKind	Hippel James CFO	C-Suite Officer	56 097 Value: $3.29M
Apr 22, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Kelderman Kim Chief Executive Officer	CEO / President	11 344 Value: $540.0K
Apr 22, 2026 Sell	Common Stock F-InKind	Kelderman Kim Chief Executive Officer	CEO / President	1 363 Value: $79.8K
Apr 22, 2026 Buy	Common Stock M-Exempt	Kelderman Kim Chief Executive Officer	CEO / President	11 344 Value: $664.5K
Apr 22, 2026 Buy	Common Stock M-Exempt	Hippel James CFO	C-Suite Officer	62 000 Value: $3.63M
Apr 22, 2026 Buy	Stock Options (Right to Buy) M-Exempt	Hippel James CFO	C-Suite Officer	62 000 Value: $2.95M
Apr 14, 2026 Sell	Common Stock F-InKind	Kelderman Kim Chief Executive Officer	CEO / President	32 088 Value: $1.88M
Apr 14, 2026 Buy	Common Stock M-Exempt	Kelderman Kim Chief Executive Officer	CEO / President	36 500 Value: $2.14M
Apr 14, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Kelderman Kim Chief Executive Officer	CEO / President	36 500 Value: $1.74M
Apr 03, 2026 Buy	Restricted Stock Units M-Exempt	Bohnen Shane SVP - General Counsel	Officer	2 259 Value: $114.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIO-TECHNE CORP

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, and diagnostics and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment provides biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, s...

Read Full Profile Here